A detailed history of Deutsche Bank Ag\ transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 49,068 shares of PTCT stock, worth $2.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,068
Previous 38,854 26.29%
Holding current value
$2.23 Million
Previous $1.19 Million 53.2%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$30.39 - $37.66 $310,403 - $384,659
10,214 Added 26.29%
49,068 $1.82 Million
Q2 2024

Aug 14, 2024

SELL
$24.69 - $40.12 $132,980 - $216,086
-5,386 Reduced 12.17%
38,854 $1.19 Million
Q1 2024

May 15, 2024

BUY
$24.15 - $31.95 $169,508 - $224,257
7,019 Added 18.86%
44,240 $1.29 Million
Q4 2023

Feb 14, 2024

SELL
$18.07 - $29.37 $2,891 - $4,699
-160 Reduced 0.43%
37,221 $1.03 Million
Q3 2023

Nov 09, 2023

BUY
$22.41 - $41.99 $114,828 - $215,156
5,124 Added 15.88%
37,381 $837,000
Q2 2023

Aug 14, 2023

SELL
$40.4 - $59.1 $636,461 - $931,061
-15,754 Reduced 32.81%
32,257 $1.31 Million
Q1 2023

May 15, 2023

SELL
$38.16 - $48.86 $560,074 - $717,118
-14,677 Reduced 23.41%
48,011 $2.33 Million
Q4 2022

Feb 13, 2023

SELL
$33.53 - $54.79 $2.36 Million - $3.85 Million
-70,304 Reduced 52.86%
62,688 $2.39 Million
Q3 2022

Nov 14, 2022

SELL
$41.85 - $53.85 $287,844 - $370,380
-6,878 Reduced 4.92%
132,992 $6.68 Million
Q2 2022

Aug 11, 2022

SELL
$25.6 - $45.23 $134,707 - $238,000
-5,262 Reduced 3.63%
139,870 $5.6 Million
Q1 2022

May 13, 2022

SELL
$33.33 - $44.6 $137,652 - $184,198
-4,130 Reduced 2.77%
145,132 $5.42 Million
Q4 2021

Feb 11, 2022

BUY
$35.36 - $41.86 $55,727 - $65,971
1,576 Added 1.07%
149,262 $5.94 Million
Q3 2021

Nov 04, 2021

SELL
$37.01 - $44.74 $182,940 - $221,149
-4,943 Reduced 3.24%
147,686 $5.5 Million
Q2 2021

Aug 11, 2021

BUY
$37.95 - $49.37 $90,472 - $117,698
2,384 Added 1.59%
152,629 $6.45 Million
Q1 2021

May 13, 2021

SELL
$46.8 - $68.92 $2.05 Million - $3.02 Million
-43,782 Reduced 22.56%
150,245 $7.11 Million
Q4 2020

Feb 16, 2021

BUY
$47.96 - $67.64 $708,561 - $999,313
14,774 Added 8.24%
194,027 $11.8 Million
Q3 2020

Nov 12, 2020

BUY
$45.41 - $57.07 $328,041 - $412,273
7,224 Added 4.2%
179,253 $8.38 Million
Q2 2020

Aug 13, 2020

SELL
$42.56 - $54.98 $826,132 - $1.07 Million
-19,411 Reduced 10.14%
172,029 $8.73 Million
Q1 2020

May 14, 2020

SELL
$32.37 - $59.36 $516,139 - $946,495
-15,945 Reduced 7.69%
191,440 $8.54 Million
Q4 2019

Feb 14, 2020

BUY
$32.22 - $50.07 $4.84 Million - $7.52 Million
150,187 Added 262.57%
207,385 $9.96 Million
Q3 2019

Nov 14, 2019

SELL
$33.82 - $48.17 $6.18 Million - $8.8 Million
-182,723 Reduced 76.16%
57,198 $1.93 Million
Q2 2019

Aug 14, 2019

SELL
$35.42 - $45.0 $30.2 Million - $38.3 Million
-852,156 Reduced 78.03%
239,921 $10.8 Million
Q1 2019

May 15, 2019

BUY
$28.09 - $39.49 $3.18 Million - $4.47 Million
113,177 Added 11.56%
1,092,077 $41.1 Million
Q4 2018

Feb 14, 2019

BUY
$29.83 - $46.51 $22.9 Million - $35.6 Million
766,443 Added 360.75%
978,900 $33.6 Million
Q3 2018

Dec 21, 2021

BUY
$33.9 - $47.77 $3.7 Million - $5.22 Million
109,229 Added 105.81%
212,457 $9.99 Million
Q3 2018

Nov 14, 2018

SELL
$33.9 - $47.77 $4.04 Million - $5.69 Million
-119,204 Reduced 53.59%
103,228 $4.85 Million
Q2 2018

Apr 21, 2020

BUY
$25.7 - $47.88 $850,207 - $1.58 Million
33,082 Added 17.47%
222,432 $7.5 Million
Q2 2018

Aug 14, 2018

SELL
$25.7 - $47.88 $8.61 Million - $16 Million
-334,840 Reduced 63.88%
189,350 $6.39 Million
Q1 2018

Oct 18, 2019

BUY
$17.46 - $32.59 $1.19 Million - $2.22 Million
68,246 Added 14.97%
524,190 $14.2 Million
Q1 2018

May 15, 2018

BUY
$17.46 - $32.59 $3.69 Million - $6.89 Million
211,486 Added 86.51%
455,944 $12.3 Million
Q4 2017

Feb 14, 2018

BUY
$15.14 - $20.89 $2.79 Million - $3.85 Million
184,304 Added 306.39%
244,458 $4.08 Million
Q3 2017

Nov 14, 2017

BUY
$16.81 - $21.61 $1.01 Million - $1.3 Million
60,154
60,154 $1.2 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.25B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.